Categories Earnings

Lower first-quarter expenses aid UnitedHealth as it raises full-year outlook

By keeping medical expenses in check despite a heavy flu season, the largest healthcare insurer in the US, UnitedHealth Group (UNH) posted a first-quarter profit beating market estimates. Shares of the UnitedHealthcare parent inched almost 3% up before the market opened on Tuesday.

With total revenue jumping 13.3% to about $55.2 billion, the health insurer saw its earnings for the quarter soar 31% higher to $2.84 billion or $2.87 per share. Optum and UnitedHealthcare segments helped the total revenue spurt.

With these results, UnitedHealth added to the consecutive positive growth just like its prior four quarters. With its diversified revenue stream aiding the US top-dog, Optum — its biggest revenue driver has been growing rapidly amid acquisitions in the industry.

Based on the positive results, UnitedHealth raised its outlook for 2018, now expecting net earnings in the range of $11.70-11.95 per share and adjusted net earnings between $12.40 and 12.65 per share.

During the first quarter, Optum grew 11.1% in revenue. The unit also reported an improvement in its operating margin by 100 basis points to 7%. And the latest $5-billion acquisition of DaVita Medical Group clinics will further bolster this arm.

In the recent years, UnitedHealth consistently outdid its rivals. The company’s strategy of diversification — like gobbling the pharmacy-benefits manager Catamaran Corp in 2015 and its constant success with Optum — is pushing others in the industry to take bolder steps in consolidation (remember the CVS Health Corp-Aetna and Cigna-Express Scripts Holding Co deals.) With these constant successes, let’s wait and watch what ripple effect these numbers have on the healthcare industry.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top